Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Curevo Vaccine Announces Positive Topline Results from Phase 2 Trial of Amezosvatein, a Next-Generation Vaccine for Shingles, Head-to-Head vs. Shingrix
Monday, January 08, 2024Curevo Vaccine a privatelyheld clinicalstage biotechnology company dedicated to developing varicella zoster virus vaccines with improved tolerability and accessibility today announced positive data
Sana Biotech's SC262 CAR T Therapy Cleared by FDA for B-cell Malignancies
Saturday, January 06, 2024Sana Biotechnology Inc a company focused on changing the possible for patients through engineered cells today announced the US Food and Drug Administration has cleared the companys Investigational New Drug
Novo Nordisk Enters Into Research Collaborations With Omega Therapeutics and Cellarity on Novel Treatment Approaches for Cardiometabolic Diseases
Friday, January 05, 2024Novo Nordisk Omega Therapeutics Inc and Cellarity Inc today announced that Novo Nordisk has entered into separate research collaborations with each company The Omega collaboration
AbbVie and Umoja Biopharma Announce Strategic Collaboration to Develop Novel In-Situ CAR-T Cell Therapies
Friday, January 05, 2024AbbVie and Umoja Biopharma an early clinicalstage biotechnology company today announced two exclusive option and license agreements to develop multiple insitu generated CART cell therapy candidates in oncology
Repare Therapeutics and Debiopharm Partner to Explore the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition in Cancer
Friday, January 05, 2024Repare Therapeutics Inc a leading clinicalstage precision oncology company today announced that it has entered into a clinical study and collaboration agreement
Bridgebio Announces FDA Clearance of Ind Application for BBO-8520, a First-in-class Direct Inhibitor of KRASG12C (ON)
Thursday, January 04, 2024BridgeBio Pharma Inc Nasdaq BBIO BridgeBio or the Company a commercialstage biopharmaceutical company focused on genetic diseases and cancers has announced that the United States Food and Drug Administration
Galapagos Establishes Strategic Collaboration With Bridgene Biosciences to Expand Small Molecule Drug Discovery in Oncology
Thursday, January 04, 2024Galapagos NV today announced that it has entered into a strategic collaboration and licensing agreement with BridGene Biosciences Inc a biotechnology company
Biora Therapeutics Progresses Research Collaboration for the BioJet™ Systemic Oral Delivery Platform
Wednesday, January 03, 2024Biora Therapeutics Inc Nasdaq BIOR the biotech company that is reimagining therapeutic delivery today announced that its BioJet Systemic Oral Delivery Platform has met key performance milestones as part of its research collaboration
Atai Life Sciences Announces Positive Topline Results From Single Ascending Dose Phase 1 Study With EMP-01 (R-MDMA)
Wednesday, January 03, 2024Atai Life Sciences a clinicalstage biopharmaceutical company aiming to transform the treatment of mental health disorders announced positive results from its Phase study evaluating
Voyager Therapeutics Enters Capsid License Agreement and Strategic Collaboration with Novartis to Advance Novel Gene Therapies
Tuesday, January 02, 2024Voyager Therapeutics Inc a biotechnology company dedicated to advancing neurogenetic medicines today announced a strategic collaboration and capsid license agreement with Novartis Pharma AG
